Press releases
* (R) = Regulatory press releases
24 Feb, 2022
(R) Cantargia publishes full year report for 2021
22 Feb, 2022
(R) Cantargia reports encouraging new CAN10 toxicology results and schedules phase I trial for 2023
08 Feb, 2022
Invitation to presentation of Cantargia’s report for the fourth quarter of 2021 on February 24 at 3.00 p.m. CET
04 Feb, 2022
(R) Cantargia reports treatment of first non-squamous non-small cell lung cancer patient in new arm of CANFOUR study
03 Feb, 2022
(R) Cantargia reports positive safety data from CIRIFOUR clinical study on nadunolimab and pembrolizumab combination
19 Jan, 2022